Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.75)
# 3,346
Out of 5,161 analysts
181
Total ratings
22.49%
Success rate
-6.49%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.05 | +757.14% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $200 | $1.86 | +10,652.69% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $4.98 | +281.53% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.25 | +220.00% | 7 | Apr 8, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $2.05 | +9,656.10% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $1.80 | +955.56% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $6.38 | +229.15% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.14 | +1,215.79% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $1.73 | +32,269.94% | 9 | Mar 10, 2025 | |
| ENVB Enveric Biosciences | Reiterates: Buy | $120 | $1.92 | +6,150.00% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $5.60 | +614.29% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $3.90 | +2,207.69% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $10.30 | +84.47% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.72 | +488.24% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.78 | +671.51% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.87 | +11,427.38% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54,000 | $3.72 | +1,451,512.90% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.64 | +657.58% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $3.27 | +481,551.38% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $9.05 | +5,424.86% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $33.71 | +611.95% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.80 | +9,900.00% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $14.19 | +56,277.73% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.60 | +337.50% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.65 | +1,718.18% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.14 | +866.18% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.52 | +411.36% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.16 | +58.23% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $60.00 | -60.00% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $0.65 | +525,407.07% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $0.88 | +2,158,990.91% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.05
Upside: +757.14%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $200
Current: $1.86
Upside: +10,652.69%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $4.98
Upside: +281.53%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.25
Upside: +220.00%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $2.05
Upside: +9,656.10%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $1.80
Upside: +955.56%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $6.38
Upside: +229.15%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.14
Upside: +1,215.79%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $1.73
Upside: +32,269.94%
Enveric Biosciences
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $1.92
Upside: +6,150.00%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $5.60
Upside: +614.29%
Mar 4, 2025
Reiterates: Buy
Price Target: $90
Current: $3.90
Upside: +2,207.69%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $10.30
Upside: +84.47%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $2.72
Upside: +488.24%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.78
Upside: +671.51%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.87
Upside: +11,427.38%
Nov 12, 2024
Reiterates: Buy
Price Target: $54,000
Current: $3.72
Upside: +1,451,512.90%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.64
Upside: +657.58%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $3.27
Upside: +481,551.38%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $9.05
Upside: +5,424.86%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $33.71
Upside: +611.95%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.80
Upside: +9,900.00%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $14.19
Upside: +56,277.73%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.60
Upside: +337.50%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.65
Upside: +1,718.18%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.14
Upside: +866.18%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $3.52
Upside: +411.36%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $3.16
Upside: +58.23%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $60.00
Upside: -60.00%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $0.65
Upside: +525,407.07%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $0.88
Upside: +2,158,990.91%